Nancy Claude
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Peroxisome Proliferator-Activated Receptors 3
- Gene expression and cancer classification 2
-
- Effects and risks of endocrine disrupting chemicals 3
- Co-authors
- André Guillouzo (8 shared papers)Catherine Spire (6 shared papers)Alexandra Rogue (5 shared papers)Manuel Brun (1 shared paper)Sébastien Anthérieu (2 shared papers)Rozenn Jossé (1 shared paper)Fabrice Nesslany (4 shared papers)Richard Weaver (2 shared papers)
In The Last Decade
Nancy Claude
18 papers receiving 555 citations
Peers
Comparison fields: 5 of 91
- Pharmacology 89
- Cancer Research 102
- Hepatology 43
- Biochemistry 39
- Health, Toxicology and Mutagenesis 58
Countries citing papers authored by Nancy Claude
This map shows the geographic impact of Nancy Claude's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Claude with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Claude more than expected).
Fields of papers citing papers by Nancy Claude
This network shows the impact of papers produced by Nancy Claude. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Claude. The network helps show where Nancy Claude may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy Claude, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 112 | |
| 2 | 2011 | 94 | |
| 3 | 2008 | 75 | |
| 4 | 2014 | 51 | |
| 5 | 2011 | 50 | |
| 6 | 2023 | 25 | |
| 7 | 1999 | 24 | |
| 8 | 2011 | 23 | |
| 9 | 2011 | 19 | |
| 10 | 2006 | 18 | |
| 11 | 2008 | 18 | |
| 12 | 2013 | 16 | |
| 13 | 2010 | 15 | |
| 14 | 2015 | 10 | |
| 15 | 2004 | 6 | |
| 16 | 2009 | 3 | |
| 17 | [Reducing the use of laboratory animals]. | 2009 | 3 |
| 18 | 2024 | 1 |
About Nancy Claude
Nancy Claude is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis, Cancer Research, Small Animals and Computational Theory and Mathematics, having authored 18 papers that have together received 563 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (5 papers), Computational Drug Discovery Methods (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Effects and risks of endocrine disrupting chemicals (3 papers), Animal testing and alternatives (3 papers), Gene expression and cancer classification (2 papers), Nanoparticles: synthesis and applications (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Pharmacology (89 citations), Cancer Research (102 citations), Hepatology (43 citations), Biochemistry (39 citations) and Health, Toxicology and Mutagenesis (58 citations). Nancy Claude has collaborated with scholars based in France, Germany and Belgium. Frequent co-authors include André Guillouzo, Catherine Spire, Alexandra Rogue, Manuel Brun, Sébastien Anthérieu, Rozenn Jossé, Fabrice Nesslany, Richard Weaver, Elisabeth Lorge and Anne Platel. Their work appears in journals such as Toxicology and Applied Pharmacology, Regulatory Toxicology and Pharmacology, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Toxicological Sciences and Mutation research. Fundamental and molecular mechanisms of mutagenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.